- Filed
- Mar 28, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 21, 2025 | 34.97M sh |
| Shares Diluted | FY 2024 · Dec 31, 2024 | 36M sh |
| Shares Diluted | FY 2024 · Dec 31, 2023 | 35.61M sh |
| Operating Cash Flow | FY 2024 · Dec 31, 2024 | $601K |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$3.78M |
| Cash And Equivalents | FY 2024 · Dec 31, 2024 | $16.16M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $9.78M |
| Stockholders Equity | FY 2024 · Dec 31, 2024 | −$8.97M |
| Stockholders Equity | FY 2024 · Dec 31, 2023 | $19.68M |
| Total Liabilities | FY 2024 · Dec 31, 2024 | $263.55M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $248.03M |
| Total Assets | FY 2024 · Dec 31, 2024 | $345.25M |
| Total Assets | FY 2024 · Dec 31, 2023 | $351.12M |
| Eps Diluted | FY 2024 · Dec 31, 2024 | −$0.80 |
| Eps Diluted | FY 2024 · Dec 31, 2023 | −$0.60 |
| Eps Basic | FY 2024 · Dec 31, 2024 | −$0.80 |
| Eps Basic | FY 2024 · Dec 31, 2023 | −$0.60 |
| Sga Expense | FY 2024 · Dec 31, 2024 | $12.11M |
| Sga Expense restated | FY 2024 · Dec 31, 2023 | $11.89M |
| Operating Income | FY 2024 · Dec 31, 2024 | −$292K |
| Operating Income | FY 2024 · Dec 31, 2023 | $5.38M |
| Revenue | FY 2024 · Dec 31, 2024 | $41.35M |
| Revenue | FY 2024 · Dec 31, 2023 | $42.17M |